Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis.

J Hematol Oncol · 2009 · PMC2663565 · PMID 19291303

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the differences in OS between CT scan responders and non-responders (24 and 18.8 months, respectively) did not reach statistical significance, there was a trend towards longer survival in responders.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.